49. A SYSTEMATIC REVIEW OF HEALTH ECONOMIC EVALUATIONS OF PD-(L)1 INHIBITORS FOR FIRST-LINE TREATMENT AMONG PATIENTS WITH HIGH PD-L1 EXPRESSION NON-SMALL CELL LUNG CANCER. Tạp chí Y học Cộng đồng, v. 65, n. Tiếng Anh, 11 thg. 122024.